Grimes & Company, Inc. Idexx Laboratories Inc Transaction History

Grimes & Company, Inc.

$3.22 Billion
Q1 2024

A detailed history of Grimes & Company, Inc. transactions in Idexx Laboratories Inc stock. As of the latest transaction made, Grimes & Company, Inc. holds 4,641 shares of IDXX stock, worth $2.22 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

4,641

Previous 4,699 1.23%

Holding current value

$2.22 Million

Previous $2.61 Million 3.95%

% of portfolio

0.08%

Previous 0.09%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 17, 2024	SELL	$515.08 - $576.87 $29,874 - $33,458	-58 Reduced 1.23%	4,641 $2.51 Million
Q4 2023 Jan 24, 2024	BUY	$391.37 - $557.56 $106,844 - $152,213	273 Added 6.17%	4,699 $2.61 Million
Q3 2023 Oct 19, 2023	BUY	$432.42 - $556.67 $432 - $556	1 Added 0.02%	4,426 $1.94 Million
Q2 2023 Jul 19, 2023	BUY	$450.7 - $503.61 $3,605 - $4,028	8 Added 0.18%	4,425 $2.22 Million
Q1 2023 Apr 20, 2023	SELL	$406.01 - $514.59 $1,218 - $1,543	-3 Reduced 0.07%	4,417 $2.21 Million

Q4 2022 Jan 25, 2023	BUY	$324.64 - $441.27 $37,008 - $50,304	114 Added 2.65%	4,420 $0
Q1 2022 May 06, 2022	SELL	$466.52 - $631.01 $6,997 - $9,465	-15 Reduced 0.35%	4,306 $2.36 Million
Q2 2019 Jul 30, 2019	SELL	$215.53 - $275.33 $161,647 - $206,497	-750 Reduced 14.79%	4,321 $1.19 Million
Q1 2019 May 02, 2019	BUY	$178.02 - $225.69 $39,342 - $49,877	221 Added 4.56%	5,071 $1.13 Million
Q2 2018 Aug 10, 2018	SELL	$185.56 - $227.9 $547,402 - $672,305	-2,950 Reduced 37.82%	4,850 $1.06 Million
Q1 2018 May 07, 2018	BUY	$157.81 - $204.73 $15,781 - $20,473	100 Added 1.3%	7,800 $1.49 Million
Q3 2017 Nov 03, 2017	BUY	$150.32 - $166.46 $1.16 Million - $1.28 Million	7,700	7,700 $1.2 Million

Others Institutions Holding IDXX

# of Institutions

1,211

Shares Held

71.7M

Call Options Held

168K

Put Options Held

394K

View Full List

About IDEXX LABORATORIES INC

Ticker IDXX
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 83,253,696
Market Cap $39.8B
Description
IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, inclu...

More about IDXX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Grimes & Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Grimes & Company, Inc. with notifications on news.

Account

Grimes & Company, Inc. Idexx Laboratories Inc Transaction History